Metformin improves salivary gland inflammation and hypofunction in murine Sjögren’s syndrome

BACKGROUND: Activated T and B cells participate in the development and progression of Sjögren’s syndrome (SS). Metformin, a first-line anti-diabetic drug, exerts anti-inflammatory and immunomodulatory effects by activating AMPK. We investigated the therapeutic effect of metformin in non-obese diabet...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ji-Won, Kim, Sung-Min, Park, Jin-Sil, Hwang, Sun-Hee, Choi, JeongWon, Jung, Kyung-Ah, Ryu, Jun-Geol, Lee, Seon-Yeong, Kwok, Seung-Ki, Cho, Mi-La, Park, Sung-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549273/
https://www.ncbi.nlm.nih.gov/pubmed/31164166
http://dx.doi.org/10.1186/s13075-019-1904-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549273/
https://www.ncbi.nlm.nih.gov/pubmed/31164166
http://dx.doi.org/10.1186/s13075-019-1904-0

Ejemplares similares